gentamicin has been researched along with Ear Diseases in 45 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Ear Diseases: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
Excerpt | Relevance | Reference |
---|---|---|
"Gentamicin is widely used in the treatment of suspected or proven neonatal sepsis." | 8.83 | One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. ( Ahmed, M; Hagan, R; Rao, SC, 2006) |
"Gentamicin and the other aminoglycosides are toxic antibiotics, but they are urgently needed to treat newborns with neonatal sepsis." | 5.17 | Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates. ( Dwijayanti, A; Louisa, M; Rundjan, L; Setiabudy, R; Simanjuntak, E; Suwento, R; Yasin, FH, 2013) |
"Gentamicin is widely used in the treatment of suspected or proven neonatal sepsis." | 4.83 | One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. ( Ahmed, M; Hagan, R; Rao, SC, 2006) |
"Gentamicin is used in pregnancy to treat infections that cause complications to the mother and fetus if left untreated." | 3.74 | Is gentamicin ototoxic to the fetus? ( Harris, C; Kirkwood, A; Koren, G; Timar, N, 2007) |
"To examine the safety and efficacy of once-daily (OD) gentamicin treatment compared with conventional 8-hourly dosing (TDS) for urinary tract infection (UTI)." | 2.71 | Treatment of urinary tract infection with gentamicin once or three times daily. ( Balakrishnan, A; Chao, SM; Chong, CY; Ng, W; Tan, AS; Tan-Kendrick, A, 2003) |
" The advantages and disadvantages of arbitrary, predictive, and pharmacokinetic methods of dosing determination are summarized." | 2.37 | Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. ( Bailie, GR; Mathews, A, 1987) |
"Gentamicin was given by the intraperitoneal route in a dose of 120 mg/kg/day." | 1.46 | Evaluation of the possible protective role of naringenin on gentamicin-induced ototoxicity: A preliminary study. ( Akakın, D; Aydogan, E; Koçak, I; Koroglu, K; Özer, ÖF; Sarac, S; Şentürk, E, 2017) |
"Current data indicate that once-daily aminoglycoside therapy is as efficacious as traditional multiple daily dosing and equally or less toxic." | 1.29 | Once-daily aminoglycoside therapy: potential ototoxicity. ( Krieff, D; Singer, C; Smith, C, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (46.67) | 18.7374 |
1990's | 7 (15.56) | 18.2507 |
2000's | 7 (15.56) | 29.6817 |
2010's | 9 (20.00) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Svistushkin, VM | 1 |
Nikiforova, GN | 1 |
Shevchik, EA | 1 |
Zolotova, AV | 1 |
Koçak, I | 1 |
Sarac, S | 1 |
Aydogan, E | 1 |
Şentürk, E | 1 |
Akakın, D | 1 |
Koroglu, K | 1 |
Özer, ÖF | 1 |
Boyd, M | 1 |
Santoro, D | 1 |
Gram, D | 1 |
Setiabudy, R | 1 |
Suwento, R | 1 |
Rundjan, L | 1 |
Yasin, FH | 1 |
Louisa, M | 1 |
Dwijayanti, A | 1 |
Simanjuntak, E | 1 |
Samiee-Zafarghandy, S | 1 |
van den Anker, JN | 1 |
McAfee, JS | 1 |
Benson, C | 1 |
Spangenberg, D | 1 |
Lattanzio, F | 1 |
Strasnick, B | 1 |
Liu, K | 1 |
Chen, D | 1 |
Guo, W | 1 |
Yu, N | 1 |
Wang, X | 1 |
Ji, F | 1 |
Hou, Z | 1 |
Yang, WY | 1 |
Yang, S | 1 |
Somdaş, MA | 1 |
Korkmaz, F | 2 |
Gürgen, SG | 2 |
Sagit, M | 2 |
Akçadağ, A | 2 |
Musiime, GM | 1 |
Seale, AC | 1 |
Moxon, SG | 1 |
Lawn, JE | 1 |
Gundogdu, R | 1 |
Ozcan, I | 1 |
Wooltorton, E | 1 |
Rutka, J | 1 |
Chong, CY | 1 |
Tan, AS | 1 |
Ng, W | 1 |
Tan-Kendrick, A | 1 |
Balakrishnan, A | 1 |
Chao, SM | 1 |
Rao, SC | 1 |
Ahmed, M | 1 |
Hagan, R | 1 |
Kirkwood, A | 1 |
Harris, C | 1 |
Timar, N | 1 |
Koren, G | 1 |
Clamp, PJ | 1 |
Daschner, FD | 1 |
Just, HM | 1 |
Jansen, W | 1 |
Lorber, R | 1 |
Noone, P | 1 |
Legge, JW | 1 |
Parravicini, L | 1 |
Arpini, A | 1 |
Bamonte, F | 1 |
Marzanatti, M | 1 |
Ongini, E | 1 |
Winerman, I | 1 |
Segal, S | 1 |
Man, A | 1 |
Gonzalez, P | 1 |
Aguado, JM | 1 |
Martin, MA | 1 |
Fernandez-Chacon, T | 1 |
Ortuño, B | 1 |
Ferriols-Lisart, R | 1 |
Alós-Almiñana, M | 1 |
Singer, C | 1 |
Smith, C | 1 |
Krieff, D | 1 |
Lang, H | 1 |
Liu, C | 1 |
Reiss, M | 1 |
Silverstein, H | 1 |
Laurell, G | 1 |
Viberg, A | 1 |
Teixeira, M | 1 |
Sterkers, O | 1 |
Ferrary, E | 1 |
Appel, GB | 1 |
Neu, HC | 1 |
Federspil, P | 1 |
Weichselbaumer, W | 1 |
Gorz, E | 1 |
Christensen, EF | 1 |
Reiffenstein, JC | 1 |
Madissoo, H | 1 |
Hansen, MM | 1 |
Winkel, O | 1 |
Kaaber, K | 1 |
Rozarth, K | 1 |
Gendeh, BS | 1 |
Said, H | 1 |
Gibb, AG | 1 |
Aziz, NS | 1 |
Zahir, ZM | 1 |
Mathews, A | 1 |
Bailie, GR | 1 |
Veldman, JE | 2 |
Meeuwsen, F | 2 |
Huizing, EH | 2 |
van Dijk, M | 1 |
Key, Q | 1 |
Takada, A | 1 |
Bledsoe, S | 1 |
Schacht, J | 1 |
McGhie, D | 1 |
Hutchison, JG | 1 |
Geddes, AM | 1 |
Selavri, TV | 1 |
Debain, JJ | 1 |
Freyss, G | 1 |
Poulain, H | 1 |
Roydhouse, N | 1 |
Dayal, VS | 1 |
Smith, EL | 1 |
McCain, WG | 1 |
Kilcoyne, AG | 1 |
Leigh, DA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Aminoglycoside Plasma Level Measurement in Neonates With Infection[NCT01624324] | 25 participants (Anticipated) | Observational | 2010-11-30 | Recruiting | |||
Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA-study)[NCT03253614] | 226 participants (Actual) | Observational | 2017-09-15 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for gentamicin and Ear Diseases
Article | Year |
---|---|
[Modern aspects of inflammatory external ear diseases treatment].
Topics: Anti-Inflammatory Agents; Clotrimazole; Ear Canal; Ear Diseases; Gentamicins; Humans; Otitis Externa | 2021 |
Risk of gentamicin toxicity in neonates treated for possible severe bacterial infection in low- and middle-income countries: Systematic Review.
Topics: Anti-Bacterial Agents; Bacterial Infections; Developing Countries; Ear Diseases; Gentamicins; Humans | 2015 |
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
Topics: Anti-Bacterial Agents; Drug Administration Schedule; Ear Diseases; Gentamicins; Humans; Infant, Newb | 2006 |
Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Drug Administrati | 1996 |
Use of a new device, the MicroWick, to deliver medication to the inner ear.
Topics: Anti-Bacterial Agents; Autoimmune Diseases; Dexamethasone; Drug Delivery Systems; Ear Diseases; Ear, | 1999 |
Gentamicin in 1978.
Topics: Amikacin; Animals; Bacterial Infections; Drug Synergism; Ear Diseases; Gentamicins; Humans; Kidney; | 1978 |
Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services.
Topics: Amikacin; Aminoglycosides; Cost-Benefit Analysis; Ear Diseases; Gentamicins; Humans; Kidney Diseases | 1987 |
[Side effects of antibiotics-aminoglycosides].
Topics: Age Factors; Aged; Animals; Anti-Bacterial Agents; Deafness; Drug Resistance, Microbial; Ear Disease | 1972 |
7 trials available for gentamicin and Ear Diseases
Article | Year |
---|---|
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; | 2013 |
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; | 2013 |
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; | 2013 |
Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
Topics: Amikacin; Anti-Bacterial Agents; Chromatography, Liquid; Ear Diseases; Female; Gentamicins; Hearing; | 2013 |
Treatment of urinary tract infection with gentamicin once or three times daily.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Drug Administration Schedule; Ear Diseas | 2003 |
Netilmicin versus tobramycin in multi-centre studies.
Topics: Acute Kidney Injury; Aged; Bacterial Infections; Clinical Trials as Topic; Ear Diseases; Female; Gen | 1984 |
Netilmicin in the treatment of immunocompromised patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy | 1984 |
Effectiveness of prophylactic antibiotic treatment in mastoid surgery.
Topics: Adolescent; Adult; Aged; Child; Clindamycin; Ear Diseases; Female; Gentamicins; Humans; Male; Mastoi | 1981 |
Once-daily aminoglycoside dosing.
Topics: Drug Administration Schedule; Ear Diseases; Gentamicins; Humans; Infections; Kidney Diseases; Prospe | 1993 |
Gentamicin-hydrocortisone ear-drops in chronic infections.
Topics: Bacterial Infections; Clinical Trials as Topic; Ear Diseases; Gentamicins; Humans; Hydrocortisone | 1973 |
30 other studies available for gentamicin and Ear Diseases
Article | Year |
---|---|
Evaluation of the possible protective role of naringenin on gentamicin-induced ototoxicity: A preliminary study.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Cochlea; Ear Diseases; Ear, Inner; Evoked P | 2017 |
In vitro antimicrobial activity of topical otological antimicrobials and Tris-EDTA against resistant Staphylococcus pseudintermedius and Pseudomonas aeruginosa isolates from dogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Dogs; Drug Resistance, Multiple, Bacte | 2019 |
Aminoglycosides and ototoxicity in neonates: is there a relation with serum concentrations?
Topics: Amikacin; Anti-Bacterial Agents; Ear Diseases; Female; Gentamicins; Hearing; Humans; Male; Sepsis | 2013 |
Jellyfish model for ototoxicity.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Ear Diseases; Gentamicins; Hair C | 2015 |
Spontaneous and Partial Repair of Ribbon Synapse in Cochlear Inner Hair Cells After Ototoxic Withdrawal.
Topics: Action Potentials; Animals; Cochlea; Disease Models, Animal; Ear Diseases; Evoked Potentials, Audito | 2015 |
N-acetylcysteine Prevents Gentamicin Ototoxicity in a Rat Model.
Topics: Acetylcysteine; Animals; Cochlea; Disease Models, Animal; Ear Diseases; Evoked Potentials, Auditory, | 2015 |
Quercetine attenuates the gentamicin-induced ototoxicity in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Apoptosis; Caspase 3; Caspase 9; Ear Diseases; Evoked | 2015 |
Ototoxic effects from gentamicin ear drops.
Topics: Anti-Bacterial Agents; Contraindications; Ear Diseases; Gentamicins; Humans; Instillation, Drug; Tym | 2002 |
Topical aminoglycosides? No. The case against using these agents in chronic ear disease.
Topics: Administration, Topical; Aminoglycosides; Chronic Disease; Ear Diseases; Gentamicins; Humans | 2003 |
Is gentamicin ototoxic to the fetus?
Topics: Anti-Bacterial Agents; Ear Diseases; Female; Fetal Diseases; Gentamicins; Humans; Infant, Newborn; P | 2007 |
Expansile properties of otowicks: an in vitro study.
Topics: Anti-Bacterial Agents; Dexamethasone; Drug Combinations; Ear Diseases; Equipment Design; Framycetin; | 2008 |
Iontophoresis in the treatment of ear chondritis.
Topics: Cartilage Diseases; Ear Diseases; Gentamicins; Humans; Iontophoresis | 1982 |
Comparative ototoxicity of amikacin, gentamicin, netilmicin, and tobramycin in guinea pigs.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Body Weight; Cochlea; Ear Diseases; Elect | 1982 |
Once-daily aminoglycoside therapy: potential ototoxicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dizziness; Ear Diseases; Female; Gentamicins; Humans | 1996 |
Apoptosis and hair cell degeneration in the vestibular sensory epithelia of the guinea pig following a gentamicin insult.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Size; Digoxigenin; DNA Fragmentation; Ear Diseases; | 1997 |
[When do ear drops help, when are they harmful?].
Topics: Administration, Topical; Chloramphenicol; Contraindications; Drug-Related Side Effects and Adverse R | 1999 |
Blood-perilymph barrier and ototoxicity: an in vivo study in the rat.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Blood; Capillary Permeability; Cisplatin; Ear | 2000 |
[The physicians duty to inform the patient before treatment with gentamicin].
Topics: Ear Diseases; Gentamicins; Germany, West; Health Education; Humans; Informed Consent | 1977 |
[Tuberculosis of the middle and external ear; a report of two cases (author's transl)].
Topics: Adult; Deafness; Ear Diseases; Ear, External; Ear, Middle; Female; Gentamicins; Humans; Isoniazid; M | 1977 |
Comparative ototoxicity of amikacin and gentamicin in cats.
Topics: Acoustic Stimulation; Action Potentials; Amikacin; Animals; Behavior, Animal; Cats; Ear Diseases; Fe | 1977 |
[Gentamicin and ototoxicity. A prospective study].
Topics: Ear Diseases; Female; Gentamicins; Hearing Disorders; Humans; Male; Prospective Studies; Vestibule, | 1976 |
Gentamicin administration via peritoneal dialysis fluid: the risk of ototoxicity.
Topics: Audiometry, Pure-Tone; Calorimetry; Dialysis Solutions; Ear Diseases; Gentamicins; Humans; Middle Ag | 1991 |
Advances in oto-immunology: new trends in functional pathology of the temporal bone.
Topics: Animals; Cholesteatoma; Cochlea; Ear Diseases; Ear, Inner; Ear, Middle; Gentamicins; Guinea Pigs; Hu | 1987 |
Progress in temporal bone histopathology. II. Immuno-technology applied to the temporal bone.
Topics: Animals; Antibodies, Monoclonal; Cholesteatoma; Ear Diseases; Gentamicins; Hair Cells, Auditory; Hum | 1985 |
An energy-dependent step in aminoglycoside ototoxicity: prevention of gentamicin ototoxicity during reduced endolymphatic potential.
Topics: Aminoglycosides; Aminooxyacetic Acid; Animals; Cochlear Microphonic Potentials; Ear Diseases; Endoly | 1985 |
Letter: Serum-gentamicin.
Topics: Ear Diseases; Gentamicins; Humans; Respiratory Tract Infections | 1974 |
[Gentamicin and auricular toxicity].
Topics: Adult; Animals; Audiometry; Deafness; Ear Diseases; Ear, Inner; Female; Gentamicins; Guinea Pigs; Hi | 1969 |
Vertigo and its treatment.
Topics: Air Pressure; Anxiety; Brain Diseases; Cardiovascular Diseases; Cervical Vertebrae; Ear Diseases; Et | 1974 |
Cochlear and vestibular gentamicin toxicity. A clinical study of systemic and topical usage.
Topics: Administration, Topical; Cochlea; Ear Diseases; Gentamicins; Hearing Disorders; Hearing Tests; Human | 1974 |
Bacteriuria again.
Topics: Bacteriuria; Ear Diseases; Gentamicins; Humans; Urea | 1971 |